AJP - Heart AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 289: H20-H29, 2005. First published March 4, 2005; doi:10.1152/ajpheart.00082.2005
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/1/H20    most recent
00082.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gupta, S.
Right arrow Articles by Sen, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gupta, S.
Right arrow Articles by Sen, S.

Inhibition of NF-{kappa}B induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive rats

Sudhiranjan Gupta, David Young, and Subha Sen

Department of Molecular Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio

Submitted 27 January 2005 ; accepted in final form 1 March 2005

The transcription factor nuclear factor (NF)-{kappa}B plays a leading role in cardiac hypertrophy associated with heart failure, but whether it is involved in cardiac mass reduction is not known. We evaluated whether inhibiting the NF-{kappa}B cascade with pyrrolidine dithiocarbamate (PDTC) in spontaneously hypertensive rats (SHRs) and age-matched Wistar-Kyoto rats (WKYs) affected hypertrophy. We measured NF-{kappa}B signaling components [NF-{kappa}B translocation, I{kappa}B{alpha}, p65, mRNA and protein levels, and I{kappa}B kinase-{beta} (IKK{beta}) activity] at 12 and 36 wk in WKYs and SHRs and at 10 wk in PDTC-treated rats (n = 9). NF-{kappa}B activation was also evaluated in rats treated for 10 wk with captopril or hydralazine alone or with either drug plus PDTC. All components were increased in SHRs compared with WKYs. After PDTC treatment, NF-{kappa}B activity was inhibited, and heart weight-to-body weight ratio in SHRs was significantly attenuated (3.52 ± 0.04 to 3.32 ± 0.05 mg/kg). Captopril treatment significantly reduced cardiac mass (3.5 vs. 3.05 mg/kg; n = 9) and inhibited NF-{kappa}B activity (169.71 ± 5.70 to 106.7 ± 12.44). Hydralazine had no effect on cardiac mass (3.5 vs. 3.42 mg/kg) or NF-{kappa}B activity (169.71 ± 5.70 to 155.52 ± 6.11). Hydralazine plus PDTC reduced blood pressure (191.16 ± 1.7 to 158.5 ± 2.36 mmHg) and inhibited NF-{kappa}B activity (169.71 ± 5.70 to 97.29 ± 3.65). Our data suggest that 1) cardiac hypertrophy in SHRs is partly due to NF-{kappa}B activation, 2) inhibition of NF-{kappa}B activity by PDTC parallels regression of hypertrophy, and 3) regression of hypertrophy is partly due to inhibition of NF-{kappa}B activity, independent of hypertension. The relationship between NF-{kappa}B activity and cardiac remodeling is causal, not coincidental.

nuclear factor-{kappa}B; pyrrolidine dithiocarbamate; captopril; hydralazine



Address for reprint requests and other correspondence: S. Sen, Dept. of Molecular Cardiology, NB 50, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195 (E-mail: sens{at}ccf.org)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Gupta, R. Maitra, D. Young, A. Gupta, and S. Sen
Silencing the myotrophin gene by RNA interference leads to the regression of cardiac hypertrophy
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H627 - H636.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Kloss, S. Meiners, A. Ludwig, and B. Dahlmann
Multiple cardiac proteasome subtypes differ in their susceptibility to proteasome inhibitors
Cardiovasc Res, July 31, 2009; (2009) cvp217v2.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. M. Elks, N. Mariappan, M. Haque, A. Guggilam, D. S. A. Majid, and J. Francis
Chronic NF-{kappa}B blockade reduces cytosolic and mitochondrial oxidative stress and attenuates renal injury and hypertension in SHR
Am J Physiol Renal Physiol, February 1, 2009; 296(2): F298 - F305.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. J. H. Smeets, B. E. J. Teunissen, A. Planavila, H. de Vogel-van den Bosch, P. H. M. Willemsen, G. J. van der Vusse, and M. van Bilsen
Inflammatory Pathways Are Activated during Cardiomyocyte Hypertrophy and Attenuated by Peroxisome Proliferator-activated Receptors PPAR{alpha} and PPAR{delta}
J. Biol. Chem., October 24, 2008; 283(43): 29109 - 29118.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. J.H. Smeets, B. E.J. Teunissen, P. H.M. Willemsen, F. A. van Nieuwenhoven, A. E. Brouns, B. J.A. Janssen, J. P.M. Cleutjens, B. Staels, G. J. van der Vusse, and M. van Bilsen
Cardiac hypertrophy is enhanced in PPAR{alpha}-/- mice in response to chronic pressure overload
Cardiovasc Res, April 1, 2008; 78(1): 79 - 89.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. E. Stansfield, R.-H. Tang, N. C. Moss, A. S. Baldwin, M. S. Willis, and C. H. Selzman
Proteasome inhibition promotes regression of left ventricular hypertrophy
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H645 - H650.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Burnier, O. Phan, and Q. Wang
High salt intake: a cause of blood pressure-independent left ventricular hypertrophy?
Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2426 - 2429.
[Full Text] [PDF]


Home page
HypertensionHome page
Y. Yu, Y.-M. Kang, Z.-H. Zhang, S.-G. Wei, Y. Chu, R. M. Weiss, and R. B. Felder
Increased Cyclooxygenase-2 Expression in Hypothalamic Paraventricular Nucleus in Rats With Heart Failure: Role of Nuclear Factor {kappa}B
Hypertension, March 1, 2007; 49(3): 511 - 518.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.